These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

76 related items for PubMed ID: 6984386

  • 1. Electrophysiological studies of Guillain-Barré syndrome with different susceptibilities to develop EAN serum on 2 strains of rats.
    Low PA, Schmelzer J, Dyck PJ, Kelly JJ.
    Electroencephalogr Clin Neurophysiol Suppl; 1982; 36():81-90. PubMed ID: 6984386
    [Abstract] [Full Text] [Related]

  • 2. Results of endoneural injection of Guillain-Barré serum in Lewis rats.
    Low PA, Schmelzer JD, Dyck PJ.
    Mayo Clin Proc; 1982 Jun; 57(6):360-4. PubMed ID: 6978979
    [Abstract] [Full Text] [Related]

  • 3. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
    Taylor JM, Pollard JD.
    Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
    [Abstract] [Full Text] [Related]

  • 4. In vivo effects of sera from Guillain-Barré subgroups: an electrophysiological and histological study on rat nerves.
    Oomes PG, van der Meché FG, Markus-Silvis L, Meulstee J, Kleyweg RP.
    Muscle Nerve; 1991 Oct; 14(10):1013-20. PubMed ID: 1658645
    [Abstract] [Full Text] [Related]

  • 5. Endoneurial effects of sera from patients with acute inflammatory polyradiculoneuropathy: electrophysiologic studies on normal and demyelinated rat nerves.
    Low PA, Schmelzer J, Dyck PJ, Kelly JJ.
    Neurology; 1982 Jul; 32(7):720-4. PubMed ID: 7201109
    [Abstract] [Full Text] [Related]

  • 6. Distribution of Foxp3(+) T-regulatory cells in experimental autoimmune neuritis rats.
    Zhang Z, Zhang ZY, Fauser U, Schluesener HJ.
    Exp Neurol; 2009 Mar; 216(1):75-82. PubMed ID: 19100737
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1.
    Archelos JJ, Mäurer M, Jung S, Miyasaka M, Tamatani T, Toyka KV, Hartung HP.
    Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363
    [Abstract] [Full Text] [Related]

  • 8. [Electrophysiological and morphological effects of the injection of Guillain-Barré sera in the sciatic nerve of the rat (author's transl)].
    Sumner A, Said G, Idy I, Metral S.
    Rev Neurol (Paris); 1982 May; 138(1):17-24. PubMed ID: 7100734
    [Abstract] [Full Text] [Related]

  • 9. Demyelination induced by serum from patients with Guillain-Barré syndrome.
    Harrison BM, Hansen LA, Pollard JD, McLeod JG.
    Ann Neurol; 1984 Feb; 15(2):163-70. PubMed ID: 6703656
    [Abstract] [Full Text] [Related]

  • 10. Clinical, electrophysiological and pathologic correlations in a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.
    Xia RH, Yosef N, Ubogu EE.
    J Neuroimmunol; 2010 Feb 26; 219(1-2):54-63. PubMed ID: 20034679
    [Abstract] [Full Text] [Related]

  • 11. Effective treatment of experimental autoimmune neuritis with human immunoglobulin.
    Lin HH, Spies JM, Lu JL, Pollard JD.
    J Neurol Sci; 2007 May 15; 256(1-2):61-7. PubMed ID: 17379248
    [Abstract] [Full Text] [Related]

  • 12. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome.
    Kieseier BC, Clements JM, Pischel HB, Wells GM, Miller K, Gearing AJ, Hartung HP.
    Ann Neurol; 1998 Apr 15; 43(4):427-34. PubMed ID: 9546322
    [Abstract] [Full Text] [Related]

  • 13. Patterns of conduction impairment in experimental allergic neuritis. An electrophysiological and histological study.
    Harvey GK, Pollard JD.
    J Neurol Neurosurg Psychiatry; 1992 Oct 15; 55(10):909-15. PubMed ID: 1331335
    [Abstract] [Full Text] [Related]

  • 14. Anti-cytokine autoantibodies in experimental autoimmune neuritis in Lewis rats.
    Zhu W, Mix E, Nennesmo I, Adem A, Zhu J.
    Exp Neurol; 2004 Dec 15; 190(2):486-94. PubMed ID: 15530887
    [Abstract] [Full Text] [Related]

  • 15. Effective treatment of experimental autoimmune neuritis with Fc fragment of human immunoglobulin.
    Lin HH, Wang MX, Spies JM, Pollard JD.
    J Neuroimmunol; 2007 May 15; 186(1-2):133-40. PubMed ID: 17482276
    [Abstract] [Full Text] [Related]

  • 16. Induction of experimental autoimmune neuritis with peripheral myelin protein-22.
    Gabriel CM, Hughes RA, Moore SE, Smith KJ, Walsh FS.
    Brain; 1998 Oct 15; 121 ( Pt 10)():1895-902. PubMed ID: 9798745
    [Abstract] [Full Text] [Related]

  • 17. Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization.
    Jung S, Gaupp S, Korn T, Köllner G, Hartung HP, Toyka KV.
    J Neurosci Res; 2004 Feb 15; 75(4):524-35. PubMed ID: 14743436
    [Abstract] [Full Text] [Related]

  • 18. CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis.
    Duan RS, Chen Z, Bao L, Quezada HC, Nennesmo I, Winblad B, Zhu J.
    Neurobiol Dis; 2004 Aug 15; 16(3):630-7. PubMed ID: 15262275
    [Abstract] [Full Text] [Related]

  • 19. Nerve ischemia in Guillain-Barré syndrome: an alternative mechanism for early conduction failure.
    Berciano J, García A.
    Rev Neurol (Paris); 2002 Mar 15; 158(3):364-5. PubMed ID: 11976600
    [No Abstract] [Full Text] [Related]

  • 20. Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis.
    Lonigro A, Devaux JJ.
    Brain; 2009 Jan 15; 132(Pt 1):260-73. PubMed ID: 18953054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.